SUBSCRIBE: Print / eNewsletter
Breast Cancer Patients With ESR1 Mutations Fare Worse
Women with ER-positive metastatic breast cancer previously treated with an aromatase inhibitor have worse survival outcomes if their tumor harbors one of two estrogen receptor mutations.
Brain Function Differs By Medulloblastoma Subtype
Patients with different molecular subtypes of medulloblastoma, a common type of childhood brain tumor, have varying decline in brain function following radiation therapy for their disease.
AR-V7 Variant Testing in Prostate Cancer Could Reduce Treatment Costs
Determining the presence of AR-V7 in prostate cancer patients could potentially save the US healthcare system $150 million each year by preventing unnecessary treatment.
Robotic Surgery On Par With Non-Robotic Surgery for Prostate Cancer
Robot-assisted and open radical surgeries for prostate cancer have similar outcomes for patients at 3 months, according to clinical trial results.
High Variability in Diagnosis of Dense Breasts
A recent study found that radiologists differ in their interpretation of whether a woman has dense breasts based on mammography.
ALK Mutation Variant May Affect Response to Targeted Agents
ALK-targeting agents such as crizotinib may work most effectively in lung cancer patients with ALK variant 1.
Acupressure Can Ease Symptoms of Breast Cancer
Acupressure, a technique derived from acupuncture, helped improve sleep and relieved chronic fatigue experienced by women treated for breast cancer.
Olanzapine Prevents Chemo-Induced Nausea
Adding the antipsychotic drug olanzapine to a standard antiemetic regimen significantly improved prevention of nausea caused by emetogenic chemotherapy.
Breast Microbiome May Play a Role in Breast Cancer
Researchers have uncovered a potential role of the bacteria found within breast tissue in the prevention and progression of breast cancer.
Could PSA Screening Predict Lethal Prostate Cancer Later in Life?
Higher than average PSA levels in middle age may be predictive of a higher risk of lethal prostate cancer later in life.